source
- Asahi Kasei Therapeutics receives FDA approval for HSV drug acquired in $1 billion dealAsahi Kasei Therapeutics announced that the U.S. Food and Drug Administration granted approval for its herpes simplex virus (HSV) therapy. The drug, called Hovilpri, was purchased by Asahi Kasei e…
- Aspen Neuroscience files for Nasdaq IPO to fund Parkinson’s cell therapy programAspen Neuroscience, founded in 2018, announced plans to list on Nasdaq, aiming to raise additional capital for its Parkinson’s disease cell therapy program. The company's lead candidate, sasinepro…